AHK-Cu is studied in copper-peptide coordination models and laboratory assays involving fibroblast and extracellular-matrix signaling.
- Copper-peptide coordination
- Fibroblast models
- Extracellular-matrix signaling
AHK-Cu is a different copper peptide from GHK-Cu
Both are labeled 50 mg. AHK-Cu is studied in copper-peptide coordination and fibroblast models under its own sequence. GHK-Cu's report splits GHK and copper. This report prints one AHK-Cu mass.
Task 105237, analyzed February 3, 2026, prints 55.25 mg and purity 99.89%.
Price gap
AHK-Cu is $34.99. GHK-Cu is $29.99. SNAP-8, which is not a copper peptide, is $29.99.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
AHK-Cu 50 mg research questions
What does the AHK-Cu report print?
55.25 mg and purity 99.89%, task 105237.
Is the label 50 mg?
Yes. The report prints 55.25 mg.
References and further reading
- PubMed literature index — AHK-Cu 50 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.
